- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04153669
Exercise With or Without Electrical Stimulation in Cystic Fibrosis (Part I): Effects on Physical Fitness (ECOMIRIN)
Effects of Exercise With or Without Electrical Stimulation in Physical Fitness in Cystic Fibrosis: an Integrated Vision (ECOMIRIN Study)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Villaviciosa De Odón, Spain, 28670
- Escuela de Doctorado e Investigacion, Universidad Europea
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of CF
- Age: 6-18 years old
- Signature of informed consent of legal guardian and patient.
Exclusion Criteria:
- Being a smoker
- Having had an exacerbation in the last 3 months
- Having undergone gastric surgery
- Having enteral nutrition at present
- The patients will come from the HIUNJ of Madrid.
- Currently taking CFTR modulators
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
This group will continue with regular visits to the specialist.
This visits include recommendations to improve lifestyle.
|
|
Experimental: Exercise-No NMES
This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle. The exercise protocol includes a concurrent exercise intervention (strength training and aerobic training), 3 days a week, 60 minutes sessions. |
Exercise-No NMES
|
Experimental: Exercise-NMES
This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle. The exercise protocol includes a concurrent exercise intervention (strength training and aerobic training), 3 days a week, 60 minutes sessions. Additionally, this group will receive neuromuscular electrical stimulation (NMES) concomitant to the strength training. |
Exercise-NMES
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Strength
Time Frame: Two assessment points throughout the study: baseline and 8 weeks after the intervention
|
Changes in strength will be measured using a five repetition maximum test (5RM)
|
Two assessment points throughout the study: baseline and 8 weeks after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Cardiorespiratory Fitness
Time Frame: Two assessment points throughout the study:baseline and 8 weeks after the intervention
|
Changes in cardiorespiratory fitness will be measured using a cardiopulmonary exercise test (CPET)
|
Two assessment points throughout the study:baseline and 8 weeks after the intervention
|
Changes in Pulmonary Function
Time Frame: Two assessment points throughout the study:baseline and 8 weeks after the intervention
|
Changes in pulmonary function will be measured using Spirometry
|
Two assessment points throughout the study:baseline and 8 weeks after the intervention
|
Changes in physical activity levels
Time Frame: Two assessment points throughout the study:baseline and 8 weeks after the intervention
|
Changes in physical activity levels will be measured using Physical Activity Questionnaire for Children and Adolescents (PAC-C or PAC-A)
|
Two assessment points throughout the study:baseline and 8 weeks after the intervention
|
Change in quality of life
Time Frame: Two assessment points throughout the study:baseline and 8 weeks after the intervention
|
Changes in quality of life will be measures with the Cystic Fibrosis-Questionnaire-Revised (CFQ-R)
|
Two assessment points throughout the study:baseline and 8 weeks after the intervention
|
Food consumption frequency
Time Frame: One assessment point at baseline:baseline and 8 weeks after the intervention
|
The food consumption frequency will be measured using food frequency questionnaire (FFQ)
|
One assessment point at baseline:baseline and 8 weeks after the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Margarita Perez Ruiz, MD, Universidad Europea de Madrid
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R-0019/18
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cystic Fibrosis in Children
-
Hospital de Clinicas de Porto AlegreUnknownCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With ExacerbationBrazil
-
Assistance Publique Hopitaux De MarseilleUnknownThe Efficacy of Azithromycin in Treating Children With Non Cystic Fibrosis Bronchiectasis (AZI-STOP)Non Cystic Fibrosis Bronchiectasis in Children
-
University of Colorado, DenverCystic Fibrosis FoundationTerminatedCystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in ChildrenUnited States
-
Royal College of Surgeons, IrelandThe Hospital for Sick Children; Imperial College London; Erasmus Medical Center; University College Dublin and other collaboratorsActive, not recruitingCystic Fibrosis | Adherence, Medication | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children | Cystic Fibrosis Liver DiseaseUnited Kingdom, Ireland
-
The Hospital for Sick ChildrenCanadian Cystic Fibrosis FoundationActive, not recruitingCystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in ChildrenCanada
-
Societe Francaise de la MucoviscidoseRecruitingCystic Fibrosis in ChildrenFrance
-
Gelb, Arthur F., M.D.The Hospital for Sick Children; Stony Brook University; Miller Children's & Women...RecruitingCystic Fibrosis in ChildrenUnited States
-
University Hospital, MontpellierCompletedCystic Fibrosis in ChildrenFrance
-
Medipol UniversityCompletedCystic Fibrosis in ChildrenTurkey
-
Boston Children's HospitalJohns Hopkins University; University of Arizona; Cystic Fibrosis FoundationCompletedCystic Fibrosis | Cystic Fibrosis in ChildrenUnited States
Clinical Trials on Exercise-No NMES
-
The Hong Kong Polytechnic UniversityUnknown
-
VA Office of Research and DevelopmentCompletedPeripheral Arterial Disease | Intermittent ClaudicationUnited States
-
University of TennesseeBlanchfield Army Community HospitalCompletedPatellofemoral Pain SyndromeUnited States
-
Royal Brompton & Harefield NHS Foundation TrustKings Clinical Trials UnitCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Kayseri City HospitalNot yet recruitingStroke | DysphagiaTurkey
-
Maastricht University Medical CenterCompletedSarcopeniaNetherlands
-
Centro de Traumatologia do EsporteCompletedMuscle Weakness | Sports PerformanceBrazil
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingAnterior Cruciate Ligament InjuryUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedSubacromial Impingement SyndromeTurkey